FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kathy Williams

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Procedures

Anatomy

Lung

Concepts & Ideas

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Rokeya Tasneen; Dinesh Taylor; Kathy N Williams; Charles A Peloquin; Koen Andries; Si-Yang Li; Khisimuzi E Mdluli; Eric Nuermberger
Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis.
Zahoor Ahmad; Austin Minkowski; Charles A Peloquin; Kathy N Williams; Khisimuzi E Mdluli; Jacques H Grosset; Eric Nuermberger
Activity of the fluoroquinolone DC-159a in the initial and continuation phases of treatment of murine tuberculosis.
Zahoor Ahmad; Eric Nuermberger; Rokeya Tasneen; Michael L Pinn; Kathy N Williams; Charles A Peloquin; Jacques H Grosset; Petros C Karakousis
Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kathy Williams (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Rokeya Tasneen; Dinesh Taylor; Kathy N Williams; Charles A Peloquin; Koen Andries; Si-Yang Li; Khisimuzi E Mdluli; Eric Nuermberger
Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2011;55(12):5485-92.
2011: Zahoor Ahmad; Austin Minkowski; Charles A Peloquin; Kathy N Williams; Khisimuzi E Mdluli; Jacques H Grosset; Eric Nuermberger
Activity of the fluoroquinolone DC-159a in the initial and continuation phases of treatment of murine tuberculosis.
Antimicrobial agents and chemotherapy 2011;55(4):1781-3.
2010: Zahoor Ahmad; Eric Nuermberger; Rokeya Tasneen; Michael L Pinn; Kathy N Williams; Charles A Peloquin; Jacques H Grosset; Petros C Karakousis
Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.
The Journal of antimicrobial chemotherapy 2010;65(4):729-34.
2009: Kathy N Williams; Steven J Brickner; C Kendall Stover; Tong Zhu; Adam Ogden; Rokeya Tasneen; Sandeep Tyagi; Jacques H Grosset; Eric Nuermberger
Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis.
American journal of respiratory and critical care medicine 2009;180(4):371-6.
2009: Kathy N Williams; C Kendall Stover; T Zhu; R Tasneen; Sandeep Tyagi; Jacques H Grosset; Eric Nuermberger
Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model.
Antimicrobial agents and chemotherapy 2009;53(4):1314-9.
2008: Eric Nuermberger; Sandeep Tyagi; Rokeya Tasneen; Kathy N Williams; Deepak Almeida; Ian M Rosenthal; Jacques H Grosset
Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2008;52(4):1522-4.
2007: Ian M Rosenthal; Ming Zhang; Kathy N Williams; Charles A Peloquin; Sandeep Tyagi; Andrew Vernon; William R Bishai; Richard E Chaisson; Jacques H Grosset; Eric Nuermberger
Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model.
PLoS medicine 2007;4(12):e344.
2006: Eric Nuermberger; Ian M Rosenthal; Sandeep Tyagi; Kathy N Williams; Deepak Almeida; Charles A Peloquin; William R Bishai; Jacques H Grosset
Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis.
Antimicrobial agents and chemotherapy 2006;50(8):2621-5.
2005: Kathy N Williams; William R Bishai
Clarithromycin extended-release in community-acquired respiratory tract infections.
Expert opinion on pharmacotherapy 2005;6(16):2867-76.
2005: Eric Nuermberger; Sandeep Tyagi; Kathy N Williams; Ian M Rosenthal; William R Bishai; Jacques H Grosset
Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model.
American journal of respiratory and critical care medicine 2005;172(11):1452-6.